# TRIAMCINOLONE ACETONIDE
> **ANDA214615** · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2023-01-19
## Drug
- **FDA Application Number:** ANDA214615
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRIAMCINOLONE ACETONIDE
- **Generic name:** TRIAMCINOLONE ACETONIDE
- **Active ingredients:** TRIAMCINOLONE ACETONIDE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Over-the-counter
- **Sponsor:** APOTEX
- **Manufacturer:** Apotex Corp.
- **First approval:** 2023-01-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214615)
---
*MORVS · CC0 1.0*